Thenappan Chandrasekar

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Medical Students

Radical Prostatectomy

Cardiovascular Events

Renal Cell Carcinoma

Top Venues

BJU international

Prostate cancer and prostatic diseases

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Rishabh K Simhal, Kerith R Wang, Yash B Shah, Costas D Lallas, Mihir S Shah, Thenappan Chandrasekar
Peri-operative outcomes following radical prostatectomy in the setting of advanced prostate cancer. BJU international (2024)
Rishabh K Simhal, Kerith R Wang, Yash B Shah, Costas D Lallas, Mihir S Shah, Thenappan Chandrasekar
Peri-operative outcomes following radical prostatectomy in the setting of advanced prostate cancer. BJU international 134 (3) (2024)
Juan F Javier-DesLoges, Marc A Dall'Era, Wayne Brisbane, Karim Chamie, Samuel L Washington, Thenappan Chandrasekar, Leonard S Marks, Hao Nguyen, Michael Daneshvar, Gregory Gin, Christopher J Kane, Aditya Bagrodia, Matthew R Cooperberg
The state of focal therapy in the treatment of prostate cancer: the university of California collaborative (UC-Squared) consensus statement. Prostate cancer and prostatic diseases (2023)
Imke Thederan, Aliaksandra Pott, Alexander Krueger, Thenappan Chandrasekar, Pierre Tennstedt, Sophie Knipper, Derya Tilki, Hans Heinzer, Karl Heinz Schulz, Nataliya Makarova, Birgit-Christiane Zyriax
Feasibility, acceptability, and behavioral outcomes of a multimodal intervention for prostate cancer patients: Experience from the MARTINI lifestyle program. The Prostate (2023)
Jessica Clark, Thenappan Chandrasekar
'Case of the Month' from Thomas Jefferson University, Philadelphia, PA, USA: a large renal pseudoaneurysm masquerading as advanced renal cell carcinoma. BJU international 128 (2) (2021)
John Panzone, Christopher Welch, Alicia K Morgans, Sumeet K Bhanvadia, Matthew Mossanen, Rachel Shenhav Goldberg, Thenappan Chandrasekar, Ruben Pinkhasov, Oleg Shapiro, Joseph M Jacob, Alina Basnet, Gennady Bratslavsky, Hanan Goldberg
Association of Race With Cancer-Related Financial Toxicity. JCO oncology practice (2021)
Hanan Goldberg, Faizan K Mohsin, Refik Saskin, Girish S Kulkarni, Alejandro Berlin, Miran Kenk, Christopher J D Wallis, Thenappan Chandrasekar, Zachary Klaassen, Olli Saarela, Linda Penn, Shabbir M H Alibhai, Neil Fleshner
The deleterious association between proton pump inhibitors and prostate cancer-specific mortality - a population-based cohort study. Prostate cancer and prostatic diseases 23 (4) (2020)
Hanan Goldberg, Rachel Glicksman, Dixon Woon, Ally Hoffman, Hina Shaikh, Thenappan Chandrasekar, Zachary Klaassen, Christopher J D Wallis, Ardalan E Ahmad, Noelia Sanmamed-Salgado, Xuanlu Qu, Fabio Y Moraes, Eleftherios P Diamandis, Alejandro Berlin, Neil E Fleshner
Can post-treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer? BJU international 127 (6) (2020)
Thenappan Chandrasekar, Hanan Goldberg, Zachary Klaassen, Christopher J D Wallis, Joon Yau Leong, Spencer Liem, Seth Teplitsky, Rodrigo Noorani, Stacy Loeb
Twitter and academic Urology in the United States and Canada: a comprehensive assessment of the Twitterverse in 2019. BJU international 125 (1) (2019)
Thenappan Chandrasekar, Marc A Dall'Era, Derya Tilki
Multiparametric MRI: an important tool to improve risk stratification for active surveillance in prostate cancer. BJU international 122 (5) (2019)
Zachary Klaassen, Christopher J D Wallis, Thenappan Chandrasekar, Hanan Goldberg, Rashid K Sayyid, Stephen B Williams, Kelvin A Moses, Martha K Terris, Robert K Nam, David Urbach, Peter C Austin, Paul Kurdyak, Girish S Kulkarni
Cancer diagnosis and risk of suicide after accounting for prediagnosis psychiatric care: A matched-cohort study of patients with incident solid-organ malignancies. Cancer 125 (16) (2019)
Thenappan Chandrasekar, Hanan Goldberg, Zachary Klaassen, Christopher J D Wallis, Dixon T S Woon, Jaime O Herrera-Caceres, Girish S Kulkarni, Neil E Fleshner
The who, when, and why of primary adrenal malignancies: Insights into the epidemiology of a rare clinical entity. Cancer 125 (7) (2018)